A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

NCT07272642 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Imaging
Colorectal Cancer
Head and Neck Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Triple Negative Breast Cancer (TNBC)

Interventions

DRUG: LNTH-2403

Sponsor

Radiopharm Theranostics, Ltd